New award for levetiracetam tablets with xlcare pharmaceuticals. Ordering period FEB 5, 2026 to may 23, 2026, with four one-year options.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79726D0019
- Awardee
-
Xlcare Pharmaceuticals Inc. UEI MEAUS5WHBJJ7
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Levetiracetam Tablets Pre-Solicitation · 36E79726R0001 · Posted Oct 21, 2025
- Last date to order 45% complete
- IDV ceiling
- $9,568,740.75
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Xlcare Pharmaceuticals Inc. on May 24, 2026, with a ceiling of $9,568,740.75 for supply of levetiracetam tablets across multiple strengths and package sizes.
Xlcare Pharmaceuticals Inc. is an economically disadvantaged woman-owned small business. The contract carries no set-aside designation.
Performance spans the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers, with distribution through VA and DoD Pharmaceutical Prime Vendor Programs. The ordering period runs from February 5, 2026 to May 23, 2026, with a base period of one year plus four one-year options extending to the ultimate completion date of May 23, 2027.
The solicitation required offerors to supply levetiracetam tablets in four strengths—250 mg, 500 mg, 750 mg, and 1,000 mg—across multiple package sizes of 60, 120, and 500 tablets per bottle, with unit-of-use packaging meeting specified bottle and safety-cap requirements. All product must carry the contractor's unique NDC number and label as the sole label. The government estimated annual usage ranging from 4,465 to 97,277 bottles depending on dosage strength and package configuration. This is a commercial item procurement under FAR Part 12. The contract incorporates Section 5 of Executive Order 14398 and FAR clause 52.222-90 addressing nondiscrimination and diversity, equity, and inclusion requirements.
NAICS code 325412 (Pharmaceutical Preparation Manufacturing); PSC 6505 (Drugs and Biologicals).
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79726D0019?
36E79726D0019 was awarded to Xlcare Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on May 24, 2026.
How much is contract 36E79726D0019 worth?
36E79726D0019's own ceiling is $9,568,741.
Who can order from contract 36E79726D0019?
36E79726D0019 is a single award indefinite delivery contract.
Was contract 36E79726D0019 competed?
The extent of competition for 36E79726D0019 was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV